NOX-A12 in Combination With Bortezomib and Dexamethasone in Relapsed Multiple Myeloma
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of NOX A12 alone and in
combination with a background therapy of bortezomib and dexamethasone (VD) chemotherapy in
previously treated patients with multiple myeloma (MM).